NJ District Court Denies Pfizer's Attempt To Block Neurontin Generic

Law360, New York (August 23, 2004, 12:00 AM EDT) -- A federal court has denied drug maker Pfizer Inc.’s attempt to bar Ivax Corp. from introducing a generic version of blockbuster epilepsy drug Neurontin.

On Friday, a judge in the U.S. District Court for the District of New Jersey denied Pfizer’s motion for a temporary restraining order and preliminary injunction which sought to block the sale by Ivax of gabapentin tablets in 100 mg, 300 mg and 400 mg strengths.

Gabapentin is the generic name of Neurontin, the epilepsy drug brought to market by Warner-Lambert, which...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.